Cross-national epidemiology of DSM-IV major depressive episode

Abstract

BackgroundMajor depression is one of the leading causes of disability worldwide, yet epidemiologic data are not available for many countries, particularly low- to middle-income countries. In this paper, we present data on the prevalence, impairment and demographic correlates of depression from 18 high and low- to middle-income countries in the World Mental Health Survey Initiative.MethodsMajor depressive episodes (MDE) as defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DMS-IV) were evaluated in face-to-face interviews using the World Health Organization Composite International Diagnostic Interview (CIDI). Data from 18 countries were analyzed in this report (n = 89,037). All countries surveyed representative, population-based samples of adults.ResultsThe average lifetime and 12-month prevalence estimates of DSM-IV MDE were 14.6% and 5.5% in the ten high-income and 11.1% and 5.9% in the eight low- to middle-income countries. The average age of onset ascertained retrospectively was 25.7 in the high-income and 24.0 in low- to middle-income countries. Functional impairment was associated with recency of MDE. The female: male ratio was about 2:1. In high-income countries, younger age was associated with higher 12-month prevalence; by contrast, in several low- to middle-income countries, older age was associated with greater likelihood of MDE. The strongest demographic correlate in high-income countries was being separated from a partner, and in low- to middle-income countries, was being divorced or widowed.ConclusionsMDE is a significant public-health concern across all regions of the world and is strongly linked to social conditions. Future research is needed to investigate the combination of demographic risk factors that are most strongly associated with MDE in the specific countries included in the WMH.

Symptoms of Depression and Risk of New Episodes of Low Back Pain: A Systematic Review and Meta‐Analysis

“…If we apply our summary OR to the worldwide prevalence of depression, we can estimate the population proportional attributable risk as the following: prevalence of depression 3 (OR 2 1)/(1 1 prevalence of depression) 3 (OR 2 1) (45), where the OR, in this example, is the OR from our overall pooling results. Considering a 12-month prevalence of depression of 6% (46), the population attributable risk would be 3.4%. As an example, in Australia this corresponds to 61,200 cases of LBP that may be partially attributable to depression, considering that LBP affects 1.8 million Australians (9.2% of the total population) (47).…”

Visual mismatch negativity (vMMN): A review and meta-analysis of studies in psychiatric and neurological disorders

“…It affects approximately one in six men and one in four women at least once during their lifetimes (Kessler, 2012;Kessler et al, 2003), and its 12-month prevalence is approximately 5.5 % (Bromet et al, 2011). The most frequent symptoms in MDD include depressed mood, sleeping problems, fatigue and suicidal thoughts or intentions, whereas bipolar disorder (BP), another diagnosis with disturbance in mood, is characterized by recurring depressive and manic periods (American Psychiatric Association, 2013).…”

Sitting-Time, Physical Activity, and Depressive Symptoms in Mid-Aged Women

“…1 Major depression has increased from the 15th cause of adult disease burden in 2000, to the 11th cause in 2010. 2 Furthermore, depressive disorders are projected to be the second leading cause of burden of disease worldwide by 2030, and the leading cause in high income countries.…”